Sun Pharma completes Taro merger As a result of the merger, Taro is now a private company and wholly owned by Sun Pharma. Maria Alfaiate joins Lundbeck as executive VP, commercial, corporate strategy Alfaiate will be part of the executive management team, and will be responsible for strengthening corporate strategic functions and enhancing global marketing efforts. Upsher-Smith honored with HDA Diana Award Upsher-Smith was named best overall branded pharmaceutical product manufacturer in its sales category for the fourth consecutive year. Strides Pharma announces completion of Bharat Dhirajlal Shah’s tenure as independent director Shah has been associated with Strides since July 2014. Alembic secures FDA approval for generic Pradaxa Dabigatran Etexilate Capsules are indicated for reduction of risk of stroke and systemic embolism in certain instances. Cranbury Pharmaceuticals receives FDA nod for generic Emflaza Deflazacort oral suspension is indicated to treat patients five years of age and older for Duchenne muscular dystrophy. Cipla receives FDA OK for generic Somatuline Depot Cipla’s lanreotide injection is indicated for the treatment of patients with acromegaly and gastroenteropancreatic neuroendocrine tumors. Lupin taps Abdelaziz Toumi as CEO of API CDMO subsidiary Toumi brings more than two decades of experience in the biotech, pharma and CDMO sectors, spanning Europe, North America and Asia. Alembic obtains FDA nod for generic Firazyr Generic Firazyr is used for the treatment of acute attacks of hereditary angioedema in adults 18 years of age and older. Glenmark receives FDA OK for generic Nexium Esomeprazole magnesium delayed-release capsules, 20 mg (OTC), will be distributed in the United States by Glenmark Therapeutics. First Previous 29 30 31 32 33 Next Last
